235 related articles for article (PubMed ID: 7141392)
1. Ursodeoxycholic acid vs. chenodeoxycholic acid as cholesterol gallstone-dissolving agents: a comparative randomized study.
Roda E; Bazzoli F; Labate AM; Mazzella G; Roda A; Sama C; Festi D; Aldini R; Taroni F; Barbara L
Hepatology; 1982; 2(6):804-10. PubMed ID: 7141392
[TBL] [Abstract][Full Text] [Related]
2. Treatment of radiolucent gallstones with CDCA or UDCA. A multicenter trial.
Polli EE; Bianchi PA; Conte D; Sironi L
Digestion; 1981; 22(4):185-91. PubMed ID: 7030835
[TBL] [Abstract][Full Text] [Related]
3. Franco-Belgian cooperative study of ursodeoxycholic acid in the medical dissolution of gallstones: a double-blind, randomized, dose-response study, and comparison with chenodeoxycholic acid.
Erlinger S; Le Go A; Husson JM; Fevery J
Hepatology; 1984; 4(2):308-14. PubMed ID: 6706305
[TBL] [Abstract][Full Text] [Related]
4. A combination of chenodeoxycholic acid and ursodeoxycholic acid is more effective than either alone in reducing biliary cholesterol saturation.
Podda M; Zuin M; Dioguardi ML; Festorazzi S; Dioguardi N
Hepatology; 1982; 2(3):334-9. PubMed ID: 7076116
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. A double-blind controlled study.
Fromm H; Roat JW; Gonzalez V; Sarva RP; Farivar S
Gastroenterology; 1983 Dec; 85(6):1257-64. PubMed ID: 6354826
[TBL] [Abstract][Full Text] [Related]
6. Retrospective comparison of 'Cheno' and 'Urso' in the medical treatment of gallstones.
Meredith TJ; Williams GV; Maton PN; Murphy GM; Saxton HM; Dowling RH
Gut; 1982 May; 23(5):382-9. PubMed ID: 7076015
[TBL] [Abstract][Full Text] [Related]
7. Different effects of chenodeoxycholic acid and ursodeoxycholic acid on serum lipoprotein concentrations in patients with radiolucent gallstones.
Leiss O; von Bergmann K
Scand J Gastroenterol; 1982 Aug; 17(5):587-92. PubMed ID: 7178821
[TBL] [Abstract][Full Text] [Related]
8. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
Iwamura K
Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
[TBL] [Abstract][Full Text] [Related]
9. Clinical studies on cheno- and ursodeoxycholic acid treatment for gallstone dissolution.
Iwamura K
Hepatogastroenterology; 1980 Feb; 27(1):26-34. PubMed ID: 7203354
[TBL] [Abstract][Full Text] [Related]
10. Effect of ursodeoxycholic acid and chenodeoxycholic acid on cholesterol and bile acid metabolism.
Tint GS; Salen G; Shefer S
Gastroenterology; 1986 Oct; 91(4):1007-18. PubMed ID: 3527851
[TBL] [Abstract][Full Text] [Related]
11. Acquired gallstone opacification during cholelitholytic treatment with chenodeoxyholic, ursodeoxycholic, and tauroursodeoxycholic acids.
Bazzoli F; Festi D; Mazzella G; Frabboni R; Zagari RM; Fossi S; Pozzato P; Sottili S; Simoni P; Roda A
Am J Gastroenterol; 1995 Jun; 90(6):978-81. PubMed ID: 7771434
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of bile acid therapy for gallstone dissolution: a meta-analysis of randomized trials.
May GR; Sutherland LR; Shaffer EA
Aliment Pharmacol Ther; 1993 Apr; 7(2):139-48. PubMed ID: 8485266
[TBL] [Abstract][Full Text] [Related]
13. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
LaRusso NF; Thistle JL
Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
[TBL] [Abstract][Full Text] [Related]
14. Lack of response to chenodeoxycholic acid in obese and non-obese patients. Role of cholesterol synthesis and possible response to ursodeoxycholic acid.
Maton PN; Murphy GM; Dowling RH
Gut; 1980 Dec; 21(12):1082-6. PubMed ID: 7461467
[TBL] [Abstract][Full Text] [Related]
15. Analysis of response to ursodeoxycholic acid for gallstone dissolution.
Bateson MC; Hill A; Bouchier IA
Digestion; 1980; 20(5):358-64. PubMed ID: 7390061
[TBL] [Abstract][Full Text] [Related]
16. Faecal bile acid loss and bile acid pool size during short-term treatment with ursodeoxycholic and chenodeoxycholic acid in patients with radiolucent gallstones.
Salvioli G; Salati R
Gut; 1979 Aug; 20(8):698-704. PubMed ID: 488763
[TBL] [Abstract][Full Text] [Related]
17. [Nucleation time and growth time in patients with cholesterol gallstone--factors affecting nucleation time and growth time and effect of UDCA and CDCA].
Nomura Y
Nihon Shokakibyo Gakkai Zasshi; 1989 May; 86(5):1103-13. PubMed ID: 2795947
[TBL] [Abstract][Full Text] [Related]
18. Hepatic cholesterol and bile acid metabolism in subjects with gallstones: comparative effects of short erm feeding of chenodeoxycholic and ursodeoxycholic acid.
Carulli N; Ponz De Leon M; Zironi F; Pinetti A; Smerieri A; Iori R; Loria P
J Lipid Res; 1980 Jan; 21(1):35-43. PubMed ID: 7354253
[TBL] [Abstract][Full Text] [Related]
19. [Oral dissolving treatment of gallbladder calculi: focus in 1989].
Erlinger S
Ann Chir; 1989; 43(6):417-9. PubMed ID: 2817740
[TBL] [Abstract][Full Text] [Related]
20. Differing effects of ursodeoxycholic or chenodeoxycholic acid on biliary cholesterol saturation and bile acid metabolism in man. A dose-response study.
Thistle JL; Larusso NF; Hofmann AF; Turcotte J; Carlson GL; Ott BJ
Dig Dis Sci; 1982 Feb; 27(2):161-8. PubMed ID: 7075411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
